Kyverna Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $26.0M | $75.2M | $34.6M |
| FY2024 | $38.1M | $304.6M | $96.6M |
| FY2025 | $61.6M | $293.8M | $124.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $26.0M | $75.2M | $34.6M |
| FY2024 | $38.1M | $304.6M | $96.6M |
| FY2025 | $61.6M | $293.8M | $124.1M |